Ventricular Assist Device Market Report: Trends, Forecast and Competitive Analysis to 2030

Ventricular Assist Device Trends and Forecast

The future of the global ventricular assist device market looks promising with opportunities in the bridge-to-transplant, destination therapy, bridge-to-recovery, and bridge to candidacy therapy applications. The global ventricular assist device market is expected to reach an estimated $3.2 billion by 2030 with a CAGR of 10.5% from 2024 to 2030. The major drivers for this market are rising prevalence of heart failure and growing number of patients with cardiovascular disease.

A more than 150-page report is developed to help in your business decisions.

Ventricular Assist Device by Segment

The study includes a forecast for the global ventricular assist device by design, product, application, end use, and region.

Ventricular Assist Device Market by Design [Shipment Analysis by Value from 2018 to 2030]:

• Transcutaneous Ventricular Assist Devices
• Implantable Ventricular Assist Devices

Ventricular Assist Device Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Left Ventricular Assist Devices (LVADs)
• Right Ventricular Assist Devices (RVADs)
• Biventricular Assist Devices (BIVADs)

Ventricular Assist Device Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Bridge-to-Transplant
• Destination Therapy
• Bridge-to-Recovery
• Bridge to Candidacy Therapy

Ventricular Assist Device Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Ambulatory Surgery Centers
• Hospital
• Others

Ventricular Assist Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Ventricular Assist Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies ventricular assist device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ventricular assist device companies profiled in this report include-

• Abbott Laboratories
• Corewave
• Bivacor
• Carmat
• Jarvik Heart

Ventricular Assist Device Market Insights

Lucintel forecasts that implantable ventricular assist device is expected to witness the higher growth over the forecast period due to its rising usage among patients with heart issue to improve the pumping function of the heart.

Within this market, destination therapy is expected to witness the highest growth.

North America is expected to witness highest growth over the forecast period due to existence of strong healthcare system and presence of key players in the region.

Features of the Global Ventricular Assist Device Market

Market Size Estimates: Ventricular assist device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Ventricular assist device market size by various segments, such as by design, product, application, end use, and region in terms of value ($B).

Regional Analysis: Ventricular assist device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different designs, products, applications, end uses, and regions for the ventricular assist device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ventricular assist device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the ventricular assist device market size?

Answer: The global ventricular assist device market is expected to reach an estimated $3.2 billion by 2030.

Q2. What is the growth forecast for ventricular assist device market?

Answer: The global ventricular assist device market is expected to grow with a CAGR of 10.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the ventricular assist device market?

Answer: The major drivers for this market are rising prevalence of heart failure and growing number of patients with cardiovascular disease.

Q4. What are the major segments for ventricular assist device market?

Answer: The future of the ventricular assist device market looks promising with opportunities in the bridge-to-transplant, destination therapy, bridge-to-recovery, and bridge to candidacy therapy applications.

Q5. Who are the key ventricular assist device market companies?

Answer: Some of the key ventricular assist device companies are as follows:

• Abbott Laboratories
• Corewave
• Bivacor
• Carmat
• Jarvik Heart

Q6. Which ventricular assist device market segment will be the largest in future?

Answer: Lucintel forecasts that implantable ventricular assist device is expected to witness the higher growth over the forecast period due to its rising usage among patients with heart issue to improve the pumping function of the heart.

Q7. In ventricular assist device market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to existence of strong healthcare system and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the ventricular assist device market by design (transcutaneous ventricular assist devices and implantable ventricular assist devices), product (left ventricular assist devices, right ventricular assist devices, and biventricular assist devices), application (bridge-to-transplant, destination therapy, bridge-to-recovery, and bridge to candidacy therapy), end use (ambulatory surgery centers, hospital, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?